Covid-19 Impact on Global Preimplantation Genetic Diagnostics (PGD) Market Size, Status and Forecast 2020-2026
This report focuses on the global Preimplantation Genetic Diagnostics (PGD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Preimplantation Genetic Diagnostics (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The key players covered in this study
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Perkinelmer, Inc.
- Cooper Surgical
- ABBott Laboratories
- Natera, Inc.
- Rubicon Genomics
- Oxford Gene Technology
- Yikon Genomics
- Scigene
- Beijing Genomics Institute (BGI)
- Genea Limited
- Hamilton Thorne
- FUJIFILM Irvine Scientific
- Nidacon International
- Vitrolife AB
- Merck
- INVO Bioscience
- IVFtech
- Gonagen Medikal
- Cook Medical
- CellCura
- Preimplantation Genetic Screening
- Preimplantation Genetic Diagnosis
- Fertility Clinics
- Academic Medical Centers
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Preimplantation Genetic Diagnostics (PGD) status, future forecast, growth opportunity, key market and key players.
- To present the Preimplantation Genetic Diagnostics (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To define, describe and forecast the market by type, market and key regions.
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Preimplantation Genetic Screening
1.4.3 Preimplantation Genetic Diagnosis
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2026
1.5.2 Fertility Clinics
1.5.3 Academic Medical Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Preimplantation Genetic Diagnostics (PGD) Industry Impact
1.6.1 How the Covid-19 is Affecting the Preimplantation Genetic Diagnostics (PGD) Industry
1.6.1.1 Preimplantation Genetic Diagnostics (PGD) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Preimplantation Genetic Diagnostics (PGD) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Preimplantation Genetic Diagnostics (PGD) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Covid-19 Implications on Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Preimplantation Genetic Diagnostics (PGD) Growth Trends by Regions
2.2.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Share by Regions (2015-2020)
2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Preimplantation Genetic Diagnostics (PGD) Market Growth Strategy
2.3.6 Primary Interviews with Key Preimplantation Genetic Diagnostics (PGD) Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Market Size
3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2015-2020)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio
3.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2019
3.3 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served
3.4 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
3.5 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)
4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2015-2020)
4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2021-2026)
5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
6.2 Preimplantation Genetic Diagnostics (PGD) Key Players in North America (2019-2020)
6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
7.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Europe (2019-2020)
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
8 CHINA
8.1 China Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
8.2 Preimplantation Genetic Diagnostics (PGD) Key Players in China (2019-2020)
8.3 China Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
8.4 China Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
9.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Japan (2019-2020)
9.3 Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
9.4 Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
10.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
10.4 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
11 INDIA
11.1 India Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
11.2 Preimplantation Genetic Diagnostics (PGD) Key Players in India (2019-2020)
11.3 India Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
11.4 India Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
12.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
12.4 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Illumina, Inc.
13.1.1 Illumina, Inc. Company Details
13.1.2 Illumina, Inc. Business Overview and Its Total Revenue
13.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020))
13.1.5 Illumina, Inc. Recent Development
13.2 Thermo Fisher Scientific Inc.
13.2.1 Thermo Fisher Scientific Inc. Company Details
13.2.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
13.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.2.5 Thermo Fisher Scientific Inc. Recent Development
13.3 Agilent Technologies, Inc.
13.3.1 Agilent Technologies, Inc. Company Details
13.3.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
13.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.3.5 Agilent Technologies, Inc. Recent Development
13.4 Perkinelmer, Inc.
13.4.1 Perkinelmer, Inc. Company Details
13.4.2 Perkinelmer, Inc. Business Overview and Its Total Revenue
13.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.4.5 Perkinelmer, Inc. Recent Development
13.5 Cooper Surgical
13.5.1 Cooper Surgical Company Details
13.5.2 Cooper Surgical Business Overview and Its Total Revenue
13.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction
13.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.5.5 Cooper Surgical Recent Development
13.6 ABBott Laboratories
13.6.1 ABBott Laboratories Company Details
13.6.2 ABBott Laboratories Business Overview and Its Total Revenue
13.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction
13.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.6.5 ABBott Laboratories Recent Development
13.7 Natera, Inc.
13.7.1 Natera, Inc. Company Details
13.7.2 Natera, Inc. Business Overview and Its Total Revenue
13.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.7.5 Natera, Inc. Recent Development
13.8 Rubicon Genomics
13.8.1 Rubicon Genomics Company Details
13.8.2 Rubicon Genomics Business Overview and Its Total Revenue
13.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
13.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.8.5 Rubicon Genomics Recent Development
13.9 Oxford Gene Technology
13.9.1 Oxford Gene Technology Company Details
13.9.2 Oxford Gene Technology Business Overview and Its Total Revenue
13.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction
13.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.9.5 Oxford Gene Technology Recent Development
13.10 Yikon Genomics
13.10.1 Yikon Genomics Company Details
13.10.2 Yikon Genomics Business Overview and Its Total Revenue
13.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
13.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.10.5 Yikon Genomics Recent Development
13.11 Scigene
10.11.1 Scigene Company Details
10.11.2 Scigene Business Overview and Its Total Revenue
10.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction
10.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.11.5 Scigene Recent Development
13.12 Beijing Genomics Institute (BGI)
10.12.1 Beijing Genomics Institute (BGI) Company Details
10.12.2 Beijing Genomics Institute (BGI) Business Overview and Its Total Revenue
10.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction
10.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.12.5 Beijing Genomics Institute (BGI) Recent Development
13.13 Genea Limited
10.13.1 Genea Limited Company Details
10.13.2 Genea Limited Business Overview and Its Total Revenue
10.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction
10.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.13.5 Genea Limited Recent Development
13.14 Hamilton Thorne
10.14.1 Hamilton Thorne Company Details
10.14.2 Hamilton Thorne Business Overview and Its Total Revenue
10.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction
10.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.14.5 Hamilton Thorne Recent Development
13.15 FUJIFILM Irvine Scientific
10.15.1 FUJIFILM Irvine Scientific Company Details
10.15.2 FUJIFILM Irvine Scientific Business Overview and Its Total Revenue
10.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction
10.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.15.5 FUJIFILM Irvine Scientific Recent Development
13.16 Nidacon International
10.16.1 Nidacon International Company Details
10.16.2 Nidacon International Business Overview and Its Total Revenue
10.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction
10.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.16.5 Nidacon International Recent Development
13.17 Vitrolife AB
10.17.1 Vitrolife AB Company Details
10.17.2 Vitrolife AB Business Overview and Its Total Revenue
10.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction
10.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.17.5 Vitrolife AB Recent Development
13.18 Merck
10.18.1 Merck Company Details
10.18.2 Merck Business Overview and Its Total Revenue
10.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction
10.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.18.5 Merck Recent Development
13.19 INVO Bioscience
10.19.1 INVO Bioscience Company Details
10.19.2 INVO Bioscience Business Overview and Its Total Revenue
10.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction
10.19.4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.19.5 INVO Bioscience Recent Development
13.20 IVFtech
10.20.1 IVFtech Company Details
10.20.2 IVFtech Business Overview and Its Total Revenue
10.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction
10.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.20.5 IVFtech Recent Development
13.21 Gonagen Medikal
10.21.1 Gonagen Medikal Company Details
10.21.2 Gonagen Medikal Business Overview and Its Total Revenue
10.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction
10.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.21.5 Gonagen Medikal Recent Development
13.22 Cook Medical
10.22.1 Cook Medical Company Details
10.22.2 Cook Medical Business Overview and Its Total Revenue
10.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction
10.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.22.5 Cook Medical Recent Development
13.23 CellCura
10.23.1 CellCura Company Details
10.23.2 CellCura Business Overview and Its Total Revenue
10.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction
10.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.23.5 CellCura Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
1.4 Covid-19 Implications on Market by Type
1.4.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Preimplantation Genetic Screening
1.4.3 Preimplantation Genetic Diagnosis
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2026
1.5.2 Fertility Clinics
1.5.3 Academic Medical Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Preimplantation Genetic Diagnostics (PGD) Industry Impact
1.6.1 How the Covid-19 is Affecting the Preimplantation Genetic Diagnostics (PGD) Industry
1.6.1.1 Preimplantation Genetic Diagnostics (PGD) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Preimplantation Genetic Diagnostics (PGD) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Preimplantation Genetic Diagnostics (PGD) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Covid-19 Implications on Global Preimplantation Genetic Diagnostics (PGD) Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Preimplantation Genetic Diagnostics (PGD) Growth Trends by Regions
2.2.1 Preimplantation Genetic Diagnostics (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Preimplantation Genetic Diagnostics (PGD) Historic Market Share by Regions (2015-2020)
2.2.3 Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Preimplantation Genetic Diagnostics (PGD) Market Growth Strategy
2.3.6 Primary Interviews with Key Preimplantation Genetic Diagnostics (PGD) Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Market Size
3.1.1 Global Top Preimplantation Genetic Diagnostics (PGD) Players by Revenue (2015-2020)
3.1.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio
3.2.1 Global Preimplantation Genetic Diagnostics (PGD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnostics (PGD) Revenue in 2019
3.3 Preimplantation Genetic Diagnostics (PGD) Key Players Head office and Area Served
3.4 Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
3.5 Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)
4.1 Global Preimplantation Genetic Diagnostics (PGD) Historic Market Size by Type (2015-2020)
4.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Type (2021-2026)
5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
5.2 Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
6.2 Preimplantation Genetic Diagnostics (PGD) Key Players in North America (2019-2020)
6.3 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
6.4 North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
7.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Europe (2019-2020)
7.3 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
7.4 Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
8 CHINA
8.1 China Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
8.2 Preimplantation Genetic Diagnostics (PGD) Key Players in China (2019-2020)
8.3 China Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
8.4 China Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
9.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Japan (2019-2020)
9.3 Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
9.4 Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
10.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
10.4 Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
11 INDIA
11.1 India Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
11.2 Preimplantation Genetic Diagnostics (PGD) Key Players in India (2019-2020)
11.3 India Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
11.4 India Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size (2015-2020)
12.2 Preimplantation Genetic Diagnostics (PGD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020)
12.4 Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Illumina, Inc.
13.1.1 Illumina, Inc. Company Details
13.1.2 Illumina, Inc. Business Overview and Its Total Revenue
13.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020))
13.1.5 Illumina, Inc. Recent Development
13.2 Thermo Fisher Scientific Inc.
13.2.1 Thermo Fisher Scientific Inc. Company Details
13.2.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
13.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.2.5 Thermo Fisher Scientific Inc. Recent Development
13.3 Agilent Technologies, Inc.
13.3.1 Agilent Technologies, Inc. Company Details
13.3.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
13.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.3.5 Agilent Technologies, Inc. Recent Development
13.4 Perkinelmer, Inc.
13.4.1 Perkinelmer, Inc. Company Details
13.4.2 Perkinelmer, Inc. Business Overview and Its Total Revenue
13.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.4.5 Perkinelmer, Inc. Recent Development
13.5 Cooper Surgical
13.5.1 Cooper Surgical Company Details
13.5.2 Cooper Surgical Business Overview and Its Total Revenue
13.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Introduction
13.5.4 Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.5.5 Cooper Surgical Recent Development
13.6 ABBott Laboratories
13.6.1 ABBott Laboratories Company Details
13.6.2 ABBott Laboratories Business Overview and Its Total Revenue
13.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Introduction
13.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.6.5 ABBott Laboratories Recent Development
13.7 Natera, Inc.
13.7.1 Natera, Inc. Company Details
13.7.2 Natera, Inc. Business Overview and Its Total Revenue
13.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Introduction
13.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.7.5 Natera, Inc. Recent Development
13.8 Rubicon Genomics
13.8.1 Rubicon Genomics Company Details
13.8.2 Rubicon Genomics Business Overview and Its Total Revenue
13.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
13.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.8.5 Rubicon Genomics Recent Development
13.9 Oxford Gene Technology
13.9.1 Oxford Gene Technology Company Details
13.9.2 Oxford Gene Technology Business Overview and Its Total Revenue
13.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Introduction
13.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.9.5 Oxford Gene Technology Recent Development
13.10 Yikon Genomics
13.10.1 Yikon Genomics Company Details
13.10.2 Yikon Genomics Business Overview and Its Total Revenue
13.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Introduction
13.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
13.10.5 Yikon Genomics Recent Development
13.11 Scigene
10.11.1 Scigene Company Details
10.11.2 Scigene Business Overview and Its Total Revenue
10.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Introduction
10.11.4 Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.11.5 Scigene Recent Development
13.12 Beijing Genomics Institute (BGI)
10.12.1 Beijing Genomics Institute (BGI) Company Details
10.12.2 Beijing Genomics Institute (BGI) Business Overview and Its Total Revenue
10.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Introduction
10.12.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.12.5 Beijing Genomics Institute (BGI) Recent Development
13.13 Genea Limited
10.13.1 Genea Limited Company Details
10.13.2 Genea Limited Business Overview and Its Total Revenue
10.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Introduction
10.13.4 Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.13.5 Genea Limited Recent Development
13.14 Hamilton Thorne
10.14.1 Hamilton Thorne Company Details
10.14.2 Hamilton Thorne Business Overview and Its Total Revenue
10.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Introduction
10.14.4 Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.14.5 Hamilton Thorne Recent Development
13.15 FUJIFILM Irvine Scientific
10.15.1 FUJIFILM Irvine Scientific Company Details
10.15.2 FUJIFILM Irvine Scientific Business Overview and Its Total Revenue
10.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Introduction
10.15.4 FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.15.5 FUJIFILM Irvine Scientific Recent Development
13.16 Nidacon International
10.16.1 Nidacon International Company Details
10.16.2 Nidacon International Business Overview and Its Total Revenue
10.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Introduction
10.16.4 Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.16.5 Nidacon International Recent Development
13.17 Vitrolife AB
10.17.1 Vitrolife AB Company Details
10.17.2 Vitrolife AB Business Overview and Its Total Revenue
10.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Introduction
10.17.4 Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.17.5 Vitrolife AB Recent Development
13.18 Merck
10.18.1 Merck Company Details
10.18.2 Merck Business Overview and Its Total Revenue
10.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Introduction
10.18.4 Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.18.5 Merck Recent Development
13.19 INVO Bioscience
10.19.1 INVO Bioscience Company Details
10.19.2 INVO Bioscience Business Overview and Its Total Revenue
10.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Introduction
10.19.4 INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.19.5 INVO Bioscience Recent Development
13.20 IVFtech
10.20.1 IVFtech Company Details
10.20.2 IVFtech Business Overview and Its Total Revenue
10.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Introduction
10.20.4 IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.20.5 IVFtech Recent Development
13.21 Gonagen Medikal
10.21.1 Gonagen Medikal Company Details
10.21.2 Gonagen Medikal Business Overview and Its Total Revenue
10.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Introduction
10.21.4 Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.21.5 Gonagen Medikal Recent Development
13.22 Cook Medical
10.22.1 Cook Medical Company Details
10.22.2 Cook Medical Business Overview and Its Total Revenue
10.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Introduction
10.22.4 Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.22.5 Cook Medical Recent Development
13.23 CellCura
10.23.1 CellCura Company Details
10.23.2 CellCura Business Overview and Its Total Revenue
10.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Introduction
10.23.4 CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
10.23.5 CellCura Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Preimplantation Genetic Diagnostics (PGD) Key Market Segments
Table 2. Key Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
Table 3. Ranking of Global Top Preimplantation Genetic Diagnostics (PGD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Preimplantation Genetic Screening
Table 6. Key Players of Preimplantation Genetic Diagnosis
Table 7. COVID-19 Impact Global Market: (Four Preimplantation Genetic Diagnostics (PGD) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Preimplantation Genetic Diagnostics (PGD) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Preimplantation Genetic Diagnostics (PGD) Players to Combat Covid-19 Impact
Table 12. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2015-2020)
Table 16. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Preimplantation Genetic Diagnostics (PGD) Market Growth Strategy
Table 22. Main Points Interviewed from Key Preimplantation Genetic Diagnostics (PGD) Players
Table 23. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2015-2020) (Million US$)
Table 24. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players (2015-2020)
Table 25. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2019)
Table 26. Global Preimplantation Genetic Diagnostics (PGD) by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
Table 29. Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 32. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Type (2015-2020)
Table 33. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2021-2026)
Table 34. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Application (2015-2020)
Table 35. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 36. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Application (2021-2026)
Table 37. North America Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 39. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 40. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 41. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 42. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 43. Europe Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 45. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 47. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 49. China Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 50. China Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 51. China Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 52. China Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 53. China Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 54. China Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 55. Japan Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 57. Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 59. Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 63. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 65. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 67. India Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 68. India Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 69. India Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 70. India Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 71. India Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 72. India Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 75. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 77. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 79. Illumina, Inc. Company Details
Table 80. Illumina, Inc. Business Overview
Table 81. Illumina, Inc. Product
Table 82. Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 83. Illumina, Inc. Recent Development
Table 84. Thermo Fisher Scientific Inc. Company Details
Table 85. Thermo Fisher Scientific Inc. Business Overview
Table 86. Thermo Fisher Scientific Inc. Product
Table 87. Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 88. Thermo Fisher Scientific Inc. Recent Development
Table 89. Agilent Technologies, Inc. Company Details
Table 90. Agilent Technologies, Inc. Business Overview
Table 91. Agilent Technologies, Inc. Product
Table 92. Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 93. Agilent Technologies, Inc. Recent Development
Table 94. Perkinelmer, Inc. Company Details
Table 95. Perkinelmer, Inc. Business Overview
Table 96. Perkinelmer, Inc. Product
Table 97. Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 98. Perkinelmer, Inc. Recent Development
Table 99. Cooper Surgical Company Details
Table 100. Cooper Surgical Business Overview
Table 101. Cooper Surgical Product
Table 102. Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 103. Cooper Surgical Recent Development
Table 104. ABBott Laboratories Company Details
Table 105. ABBott Laboratories Business Overview
Table 106. ABBott Laboratories Product
Table 107. ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 108. ABBott Laboratories Recent Development
Table 109. Natera, Inc. Company Details
Table 110. Natera, Inc. Business Overview
Table 111. Natera, Inc. Product
Table 112. Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 113. Natera, Inc. Recent Development
Table 114. Rubicon Genomics Business Overview
Table 115. Rubicon Genomics Product
Table 116. Rubicon Genomics Company Details
Table 117. Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 118. Rubicon Genomics Recent Development
Table 119. Oxford Gene Technology Company Details
Table 120. Oxford Gene Technology Business Overview
Table 121. Oxford Gene Technology Product
Table 122. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 123. Oxford Gene Technology Recent Development
Table 124. Yikon Genomics Company Details
Table 125. Yikon Genomics Business Overview
Table 126. Yikon Genomics Product
Table 127. Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 128. Yikon Genomics Recent Development
Table 129. Scigene Company Details
Table 130. Scigene Business Overview
Table 131. Scigene Product
Table 132. Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 133. Scigene Recent Development
Table 134. Beijing Genomics Institute (BGI) Company Details
Table 135. Beijing Genomics Institute (BGI) Business Overview
Table 136. Beijing Genomics Institute (BGI) Product
Table 137. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 138. Beijing Genomics Institute (BGI) Recent Development
Table 139. Genea Limited Company Details
Table 140. Genea Limited Business Overview
Table 141. Genea Limited Product
Table 142. Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 143. Genea Limited Recent Development
Table 144. Hamilton Thorne Company Details
Table 145. Hamilton Thorne Business Overview
Table 146. Hamilton Thorne Product
Table 147. Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 148. Hamilton Thorne Recent Development
Table 149. FUJIFILM Irvine Scientific Company Details
Table 150. FUJIFILM Irvine Scientific Business Overview
Table 151. FUJIFILM Irvine Scientific Product
Table 152. FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 153. FUJIFILM Irvine Scientific Recent Development
Table 154. Nidacon International Company Details
Table 155. Nidacon International Business Overview
Table 156. Nidacon International Product
Table 157. Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 158. Nidacon International Recent Development
Table 159. Vitrolife AB Company Details
Table 160. Vitrolife AB Business Overview
Table 161. Vitrolife AB Product
Table 162. Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 163. Vitrolife AB Recent Development
Table 164. Merck Company Details
Table 165. Merck Business Overview
Table 166. Merck Product
Table 167. Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 168. Merck Recent Development
Table 169. INVO Bioscience Company Details
Table 170. INVO Bioscience Business Overview
Table 171. INVO Bioscience Product
Table 172. INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 173. INVO Bioscience Recent Development
Table 174. IVFtech Company Details
Table 175. IVFtech Business Overview
Table 176. IVFtech Product
Table 177. IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 178. IVFtech Recent Development
Table 179. Gonagen Medikal Company Details
Table 180. Gonagen Medikal Business Overview
Table 181. Gonagen Medikal Product
Table 182. Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 183. Gonagen Medikal Recent Development
Table 184. Cook Medical Company Details
Table 185. Cook Medical Business Overview
Table 186. Cook Medical Product
Table 187. Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 188. Cook Medical Recent Development
Table 189. CellCura Company Details
Table 190. CellCura Business Overview
Table 191. CellCura Product
Table 192. CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 193. CellCura Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
Table 1. Preimplantation Genetic Diagnostics (PGD) Key Market Segments
Table 2. Key Players Covered: Ranking by Preimplantation Genetic Diagnostics (PGD) Revenue
Table 3. Ranking of Global Top Preimplantation Genetic Diagnostics (PGD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Preimplantation Genetic Screening
Table 6. Key Players of Preimplantation Genetic Diagnosis
Table 7. COVID-19 Impact Global Market: (Four Preimplantation Genetic Diagnostics (PGD) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Preimplantation Genetic Diagnostics (PGD) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Preimplantation Genetic Diagnostics (PGD) Players to Combat Covid-19 Impact
Table 12. Global Preimplantation Genetic Diagnostics (PGD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2015-2020)
Table 16. Global Preimplantation Genetic Diagnostics (PGD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Preimplantation Genetic Diagnostics (PGD) Market Growth Strategy
Table 22. Main Points Interviewed from Key Preimplantation Genetic Diagnostics (PGD) Players
Table 23. Global Preimplantation Genetic Diagnostics (PGD) Revenue by Players (2015-2020) (Million US$)
Table 24. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players (2015-2020)
Table 25. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2019)
Table 26. Global Preimplantation Genetic Diagnostics (PGD) by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Preimplantation Genetic Diagnostics (PGD) Product Solution and Service
Table 29. Date of Enter into Preimplantation Genetic Diagnostics (PGD) Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 32. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Type (2015-2020)
Table 33. Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Type (2021-2026)
Table 34. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Application (2015-2020)
Table 35. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 36. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Application (2021-2026)
Table 37. North America Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 39. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 40. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 41. North America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 42. North America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 43. Europe Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 45. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 47. Europe Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 49. China Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 50. China Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 51. China Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 52. China Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 53. China Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 54. China Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 55. Japan Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 57. Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 59. Japan Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 63. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 65. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 67. India Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 68. India Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 69. India Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 70. India Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 71. India Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 72. India Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Preimplantation Genetic Diagnostics (PGD) Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Preimplantation Genetic Diagnostics (PGD) Market Share (2019-2020)
Table 75. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Share by Type (2015-2020)
Table 77. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2015-2020)
Table 79. Illumina, Inc. Company Details
Table 80. Illumina, Inc. Business Overview
Table 81. Illumina, Inc. Product
Table 82. Illumina, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 83. Illumina, Inc. Recent Development
Table 84. Thermo Fisher Scientific Inc. Company Details
Table 85. Thermo Fisher Scientific Inc. Business Overview
Table 86. Thermo Fisher Scientific Inc. Product
Table 87. Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 88. Thermo Fisher Scientific Inc. Recent Development
Table 89. Agilent Technologies, Inc. Company Details
Table 90. Agilent Technologies, Inc. Business Overview
Table 91. Agilent Technologies, Inc. Product
Table 92. Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 93. Agilent Technologies, Inc. Recent Development
Table 94. Perkinelmer, Inc. Company Details
Table 95. Perkinelmer, Inc. Business Overview
Table 96. Perkinelmer, Inc. Product
Table 97. Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 98. Perkinelmer, Inc. Recent Development
Table 99. Cooper Surgical Company Details
Table 100. Cooper Surgical Business Overview
Table 101. Cooper Surgical Product
Table 102. Cooper Surgical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 103. Cooper Surgical Recent Development
Table 104. ABBott Laboratories Company Details
Table 105. ABBott Laboratories Business Overview
Table 106. ABBott Laboratories Product
Table 107. ABBott Laboratories Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 108. ABBott Laboratories Recent Development
Table 109. Natera, Inc. Company Details
Table 110. Natera, Inc. Business Overview
Table 111. Natera, Inc. Product
Table 112. Natera, Inc. Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 113. Natera, Inc. Recent Development
Table 114. Rubicon Genomics Business Overview
Table 115. Rubicon Genomics Product
Table 116. Rubicon Genomics Company Details
Table 117. Rubicon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 118. Rubicon Genomics Recent Development
Table 119. Oxford Gene Technology Company Details
Table 120. Oxford Gene Technology Business Overview
Table 121. Oxford Gene Technology Product
Table 122. Oxford Gene Technology Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 123. Oxford Gene Technology Recent Development
Table 124. Yikon Genomics Company Details
Table 125. Yikon Genomics Business Overview
Table 126. Yikon Genomics Product
Table 127. Yikon Genomics Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 128. Yikon Genomics Recent Development
Table 129. Scigene Company Details
Table 130. Scigene Business Overview
Table 131. Scigene Product
Table 132. Scigene Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 133. Scigene Recent Development
Table 134. Beijing Genomics Institute (BGI) Company Details
Table 135. Beijing Genomics Institute (BGI) Business Overview
Table 136. Beijing Genomics Institute (BGI) Product
Table 137. Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 138. Beijing Genomics Institute (BGI) Recent Development
Table 139. Genea Limited Company Details
Table 140. Genea Limited Business Overview
Table 141. Genea Limited Product
Table 142. Genea Limited Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 143. Genea Limited Recent Development
Table 144. Hamilton Thorne Company Details
Table 145. Hamilton Thorne Business Overview
Table 146. Hamilton Thorne Product
Table 147. Hamilton Thorne Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 148. Hamilton Thorne Recent Development
Table 149. FUJIFILM Irvine Scientific Company Details
Table 150. FUJIFILM Irvine Scientific Business Overview
Table 151. FUJIFILM Irvine Scientific Product
Table 152. FUJIFILM Irvine Scientific Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 153. FUJIFILM Irvine Scientific Recent Development
Table 154. Nidacon International Company Details
Table 155. Nidacon International Business Overview
Table 156. Nidacon International Product
Table 157. Nidacon International Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 158. Nidacon International Recent Development
Table 159. Vitrolife AB Company Details
Table 160. Vitrolife AB Business Overview
Table 161. Vitrolife AB Product
Table 162. Vitrolife AB Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 163. Vitrolife AB Recent Development
Table 164. Merck Company Details
Table 165. Merck Business Overview
Table 166. Merck Product
Table 167. Merck Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 168. Merck Recent Development
Table 169. INVO Bioscience Company Details
Table 170. INVO Bioscience Business Overview
Table 171. INVO Bioscience Product
Table 172. INVO Bioscience Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 173. INVO Bioscience Recent Development
Table 174. IVFtech Company Details
Table 175. IVFtech Business Overview
Table 176. IVFtech Product
Table 177. IVFtech Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 178. IVFtech Recent Development
Table 179. Gonagen Medikal Company Details
Table 180. Gonagen Medikal Business Overview
Table 181. Gonagen Medikal Product
Table 182. Gonagen Medikal Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 183. Gonagen Medikal Recent Development
Table 184. Cook Medical Company Details
Table 185. Cook Medical Business Overview
Table 186. Cook Medical Product
Table 187. Cook Medical Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 188. Cook Medical Recent Development
Table 189. CellCura Company Details
Table 190. CellCura Business Overview
Table 191. CellCura Product
Table 192. CellCura Revenue in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020) (Million US$)
Table 193. CellCura Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type: 2020 VS 2026
Figure 2. Preimplantation Genetic Screening Features
Figure 3. Preimplantation Genetic Diagnosis Features
Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2026
Figure 5. Fertility Clinics Case Studies
Figure 6. Academic Medical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions: 2020 VS 2026
Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players in 2019
Figure 14. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2019
Figure 16. North America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Illumina, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 25. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Thermo Fisher Scientific Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 27. Agilent Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Agilent Technologies, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 29. Perkinelmer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Perkinelmer, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 31. Cooper Surgical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Cooper Surgical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 33. ABBott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. ABBott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 35. Natera, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Natera, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 37. Rubicon Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Rubicon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 39. Oxford Gene Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 41. Yikon Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 43. Scigene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Scigene Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 45. Beijing Genomics Institute (BGI) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 47. Genea Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 49. Hamilton Thorne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Hamilton Thorne Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 51. FUJIFILM Irvine Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. FUJIFILM Irvine Scientific Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 53. Nidacon International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Nidacon International Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 55. Vitrolife AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Vitrolife AB Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 57. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merck Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 59. INVO Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. INVO Bioscience Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 61. IVFtech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. IVFtech Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type: 2020 VS 2026
Figure 2. Preimplantation Genetic Screening Features
Figure 3. Preimplantation Genetic Diagnosis Features
Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application: 2020 VS 2026
Figure 5. Fertility Clinics Case Studies
Figure 6. Academic Medical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. Preimplantation Genetic Diagnostics (PGD) Report Years Considered
Figure 9. Global Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions: 2020 VS 2026
Figure 11. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Players in 2019
Figure 14. Global Top Preimplantation Genetic Diagnostics (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2019
Figure 16. North America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Preimplantation Genetic Diagnostics (PGD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Illumina, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 25. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Thermo Fisher Scientific Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 27. Agilent Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Agilent Technologies, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 29. Perkinelmer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Perkinelmer, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 31. Cooper Surgical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Cooper Surgical Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 33. ABBott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. ABBott Laboratories Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 35. Natera, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Natera, Inc. Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 37. Rubicon Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Rubicon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 39. Oxford Gene Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Oxford Gene Technology Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 41. Yikon Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Yikon Genomics Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 43. Scigene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Scigene Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 45. Beijing Genomics Institute (BGI) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Beijing Genomics Institute (BGI) Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 47. Genea Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Genea Limited Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 49. Hamilton Thorne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Hamilton Thorne Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 51. FUJIFILM Irvine Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. FUJIFILM Irvine Scientific Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 53. Nidacon International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Nidacon International Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 55. Vitrolife AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Vitrolife AB Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 57. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Merck Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 59. INVO Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. INVO Bioscience Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 61. IVFtech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. IVFtech Revenue Growth Rate in Preimplantation Genetic Diagnostics (PGD) Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
